Frank B. McGuyer

Fondatore presso McGuyer Homebuilders, Inc.

72 anni

Consumer Durables

Health Technology

Consumer Services

Profilo

Frank B.
McGuyer is the founder.
He founded McGuyer Homebuilders, Inc. in 1988 and currently holds the title of Executive Chairman.
He also served as an Independent Director at Bellicum Pharmaceuticals, Inc. from 2009 to 2018.
In terms of education, Mr. McGuyer attended Southern Methodist University where he obtained an undergraduate degree.

Posizioni attive di Frank B. McGuyer

Società	Posizione	Inizio
McGuyer Homebuilders, Inc. McGuyer Homebuilders, Inc. HomebuildingConsumer Durables McGuyer Homebuilders, Inc. builds single-family residential homes. It markets homes under the brand names Coventry Homes, Pioneer Homes and Plantation Homes. The company was founded by Frank B. McGuyer and Mike Love in 1988 and is headquartered in Houston, TX.	Fondatore	01/01/1988

Tutte le posizioni attive di Frank B. McGuyer

Precedenti posizioni note di Frank B. McGuyer

Società	Posizione	Fine
BELLICUM PHARMACEUTICALS, INC.	Direttore/Membro del Consiglio	20/12/2018

Vedi nel dettaglio l'esperienza di Frank B. McGuyer

Formazione di Frank B. McGuyer

Southern Methodist University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Frank B. McGuyer

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
McGuyer Homebuilders, Inc. McGuyer Homebuilders, Inc. HomebuildingConsumer Durables McGuyer Homebuilders, Inc. builds single-family residential homes. It markets homes under the brand names Coventry Homes, Pioneer Homes and Plantation Homes. The company was founded by Frank B. McGuyer and Mike Love in 1988 and is headquartered in Houston, TX.	Consumer Durables
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.	Health Technology